GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Stella Diagnostics Inc (OTCPK:SLDX) » Definitions » Total Payout Yield %

Stella Diagnostics (Stella Diagnostics) Total Payout Yield % : 0.00 (As of Jun. 05, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Stella Diagnostics Total Payout Yield %?

Total Payout Yield % is the percent a company has paid to its shareholders through net repurchases of shares and dividends based on its Market Cap. It is a measure of shareholder return.

Stella Diagnostics's current Total Payout Yield % is 0.00%.


Stella Diagnostics Total Payout Yield % Historical Data

The historical data trend for Stella Diagnostics's Total Payout Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stella Diagnostics Total Payout Yield % Chart

Stella Diagnostics Annual Data
Trend
Total Payout Yield %

Stella Diagnostics Quarterly Data
Sep22 Sep23
Total Payout Yield % - -

Competitive Comparison of Stella Diagnostics's Total Payout Yield %

For the Diagnostics & Research subindustry, Stella Diagnostics's Total Payout Yield %, along with its competitors' market caps and Total Payout Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stella Diagnostics's Total Payout Yield % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Stella Diagnostics's Total Payout Yield % distribution charts can be found below:

* The bar in red indicates where Stella Diagnostics's Total Payout Yield % falls into.



Stella Diagnostics Total Payout Yield % Calculation

Total Payout Yield % is a measure of shareholder return.

Stella Diagnostics's Total Payout Yield % for the fiscal year that ended in . 20 is calculated as

Total Payout Yield %=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Market Cap
=- ( + + ) /
=N/A%

Stella Diagnostics's annualized Total Payout Yield % for the quarter that ended in Sep. 2023 is calculated as

Total Payout Yield %=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) * Annualized Factor / Market Cap
=- (0 + 0 + 0) * 4 / 40.16
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Stella Diagnostics Total Payout Yield % Explanation

Similar to Dividend Yield, Total Payout Yield % is a measurement of shareholder return. Dividends is not the only way that companies are able to distribute their excess cash back to the shareholders. The other way to distribute the cash is a stock repurchase. The stock repurchase buys back the company's own shares from the marketplace. This results in a reduced number of oustanding shares, making each share worth a greater percentage of the corporation.


Stella Diagnostics Total Payout Yield % Related Terms

Thank you for viewing the detailed overview of Stella Diagnostics's Total Payout Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Stella Diagnostics (Stella Diagnostics) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
50 West Broadway, Suite 300, Salt Lake City, UT, USA, 84104
Stella Diagnostics Inc is a molecular diagnostics-based organization focused on improving patient management strategies for people living with severe esophageal disease. It is developing first-line diagnostic tools that provide superior molecular information for providers as compared to the current standard screening protocols.

Stella Diagnostics (Stella Diagnostics) Headlines

From GuruFocus